COMPANY
HydroCision
HydroCision, Inc., is a privately held medical device company focused on the commercialization of its proprietary FluidJet technology. From company website Source · Oct 13, 2026
Timeline
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT03487250 | Percutaneous US Guided Elbow Tenotomy With the TenJet HydroSurgery System | Not listed | Completed | Aug 4, 2016 | Apr 20, 2019 (actual) |
FDA records (last 2 years)
- FDA 510(k) clearance: SpineSite Endoscope System — K241990, Jul 30, 2025. Applicant at approval: Hydrocision, Inc. source ↗
NIH awards 1
- NIH award 1R43DK136439-01 FY2023: $300,000 awarded for that fiscal year; activity R43 (SBIR); PI KOWALSKI, PAUL; recipient as written: HYDROCISION INC, NORTH BILLERICA, MA. Development of a Dedicated Fluidjet Technol source ↗
Connect
See your connections at HydroCision on LinkedIn (search by name, results not checked)